Status | Study |
Completed |
Study Name: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases Condition: Primary Immune Deficiency Disorders Common Variable Immunodeficiency Date: 2013-09-13 Interventions: Biological: Gammaplex (5%) Biological: Gam |
Active, not recruiting |
Study Name: Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases Condition: Primary Immune Deficiency Disorders Common Variable Immunodeficiency Date: 2013-06-14 Interventions: Biological: Subgam Subgam-VF dose will be given as 1.37 of the established IGIV dose (expressed in mg/kg |
Recruiting |
Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Condition: SCID Omenn's Syndrome Reticular Dysgenesis Date: 2012-07-25 Interventions: Drug: Alemtuzumab 0.3 mg 0.3 m |
Completed |
Study Name: A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Condition: Primary Immune Deficiency Disorders Common Variable Immunodeficiency Date: 2011-01-27 Interventions: Biological: Gammaplex GAMMAPLEX 5g/100 mL, dose is 300-800 mg/kg/infusion every 21 or 28 days, intraveno |
Completed |
Study Name: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Condition: Sickle Cell Disease Thalassemia Anemia Date: 2008-08-06 Interventions: Procedure: Hematopoietic stem cell transplantation hematopoietic stem cell transplantation conditioning |
Completed |
Study Name: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects Condition: Primary Immune Deficiency Disease Date: 2008-03-05 Interventions: Biological: Flebogamma 5% DIF Intravenous Immune Globulin (Human) |
Completed |
Study Name: A Clinical Study of Intravenous Immunoglobulin Condition: Immunologic Deficiency Syndromes Date: 2007-05-01 Interventions: Drug: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV IGIV infusions of 300-900 mg/kg every 3 or 4 w |
Terminated |
Study Name: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States Condition: Hyper-IgM Syndrome Ectodermal Dysplasia Date: 2005-12-16 |
Enrolling by invitation |
Study Name: Molecular and Clinical Studies of Primary Immunodeficiency Diseases Condition: Immunologic Deficiency Syndrome Date: 2000-09-30 |
Terminated |
Study Name: Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies Condition: Immunologic Deficiency Syndromes Chediak-Higashi Syndrome Date: 2000-07-05 Interventions: Drug: anti-thymocyte globulin Drug: busulf |